JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:2329-2334, doi:10.1016/j.jacc.2005.09.016
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v51,p2197)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carson, P.
Right arrow Articles by Bristow, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carson, P.
Right arrow Articles by Bristow, M. R.

CLINICAL RESEARCH: SAFETY ISSUE

Mode of Death in Advanced Heart Failure

The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial

Peter Carson, MD, FACC*,*, Inder Anand, MD, FACC{dagger}, Christopher O’Connor, MD, FACC{ddagger}, Brian Jaski, MD, FACC§, Jonathan Steinberg, MD, FACC||, Amy Lwin, RN, JoAnn Lindenfeld, MD, FACC#, Jalil Ghali, MD, FACC**, Jodi H. Barnet, MS{dagger}{dagger}, Arthur M. Feldman, MD, PhD, FACC{ddagger}{ddagger} and Michael R. Bristow, MD, PhD, FACC#

* Veterans Affairs Medical Center, Washington, DC
{dagger} Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, Minnesota
{ddagger} Division of Cardiology, Duke University, Durham, North Carolina
§ Advanced Heart Failure and Cardiac Transplant Programs, Sharp Memorial Hospital, San Diego, California
|| Division of Cardiology, St. Luke’s-Roosevelt Hospital, New York, New York
Clinical Cardiovascular Research, Gaithersburg, Maryland
# Division of Cardiology, University of Colorado, Denver, Colorado
** Louisiana State University Medical Center, Shreveport, Louisiana
{dagger}{dagger} University of Wisconsin, Madison, Wisconsin
{ddagger}{ddagger} Jefferson Medical College, Philadelphia, Pennsylvania

Manuscript received March 1, 2005; revised manuscript received August 24, 2005, accepted September 8, 2005.

* Reprint requests and correspondence: Dr. Peter E. Carson, Division of Cardiology, Veterans Affairs Medical Center, 50 Irving Street NW, Washington, DC 20422 (Email: Peter.Carson{at}med.va.gov).

OBJECTIVES: The aim of this study was to evaluate the mode of death in patients with advanced chronic heart failure (HF) and intraventricular conduction delay treated with optimal pharmacologic therapy (OPT) alone or OPT with biventricular pacing to provide cardiac resynchronization therapy (CRT) or CRT + an implantable defibrillator (CRT-D).

BACKGROUND: Limited data are available on mode of death in advanced HF. No data have existed on mode of death in these patients who also have an intraventricular conduction delay and are treated with CRT or CRT-D.

METHODS: Using prespecified definitions and source materials, seven cardiologists assessed mode of death among the 313 deaths that occurred in the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.

RESULTS: A primary cardiac cause was present in 78% of deaths. Pump failure (44.4%) was the most common mode of death followed by sudden cardiac death (SCD) (26.5%). Compared with OPT, CRT-D significantly reduced the number of cardiac deaths (38%, p = 0.006), whereas CRT alone was associated with a non-significant 14.5% reduction (p = 0.33). Both CRT and CRT-D tended to reduce pump failure deaths (29%, p = 0.11 and 27%, p = 0.14, respectively). The CRT-D significantly reduced SCD (56%, p = 0.02), but CRT alone did not.

CONCLUSIONS: Pump failure deaths are the predominant mode of death in patients with advanced HF and are modestly reduced by both CRT and CRT-D. Only CRT-D reduced SCD and thus produced a favorable effect on cardiac mortality.

Abbreviations and Acronyms
  CI = confidence interval
  COMPANION = Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure trial
  CRT = cardiac resynchronization therapy
  CRT-D = cardiac resynchronization therapy with defibrillator
  HF = heart failure
  HR = hazard ratio
  ICD = implantable cardioverter-defibrillator
  NYHA = New York Heart Association
  OPT = optimal pharmacologic therapy
  SCD = sudden cardiac death




This article has been cited by other articles:


Home page
EuropaceHome page
L. Ding, W. Hua, H. Niu, K. Chen, and S. Zhang
Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
Europace, September 1, 2008; 10(9): 1034 - 1041.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Patel and J. T. Heywood
Mode of Death in Patients With Systolic Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2007; 12(2): 127 - 136.
[Abstract] [PDF]


Home page
CirculationHome page
J. D. Burkhardt and B. L. Wilkoff
Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure
Circulation, April 24, 2007; 115(16): 2208 - 2220.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Lindenfeld, A. M. Feldman, L. Saxon, J. Boehmer, P. Carson, J. K. Ghali, I. Anand, S. Singh, J. S. Steinberg, B. Jaski, et al.
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
Circulation, January 16, 2007; 115(2): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Yao, N. Freemantle, M. J. Calvert, S. Bryan, J.-C. Daubert, and J. G.F. Cleland
The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator
Eur. Heart J., January 1, 2007; 28(1): 42 - 51.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. A. Saxon, M. R. Bristow, J. Boehmer, S. Krueger, D. A. Kass, T. De Marco, P. Carson, L. DiCarlo, A. M. Feldman, E. Galle, et al.
Predictors of Sudden Cardiac Death and Appropriate Shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
Circulation, December 19, 2006; 114(25): 2766 - 2772.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Ward, S. Guo, and J. J. Caro
Cost-Effectiveness of Cardiac Resynchronization Therapy
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1283 - 1283.
[Full Text] [PDF]


Home page
Eur Heart JHome page
L. A. Saxon
More is better with cardiac resynchronization therapy--but is it enough?
Eur. Heart J., August 2, 2006; 27(16): 1891 - 1892.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.